A statement released earlier today by Vetr Inc. about AFLAC Incorporated (NYSE:AFL) bumps the target price to $74.76
- Updated: October 17, 2016
Vetr Inc. bumped up the target of AFLAC Incorporated (NYSE:AFL) to $74.76 stating a potential upside of 0.06%.
Boasting a price of $70.62, AFLAC Incorporated (NYSE:AFL) traded -0.48% lower on the day. With the last stock price close up 0.03% from the two hundred day average, compared with the S&P 500 Index which has decreased -0.01% over the date range. AFLAC Incorporated has recorded a 50-day average of $72.36 and a two hundred day average of $70.60. Volume of trade was down over the average, with 1,296,800 shares of AFL changing hands under the typical 1,609,780
With a total market value of $0, AFLAC Incorporated has price-earnings ratio of 11.61 with a one year low of $54.57 and a one year high of $74.50 .
A total of 12 equity analysts have released a research note on AFL. Two equity analysts rating the company a strong buy, one equity analyst rating the company a buy, thirteen equity analysts rating the company a hold, one equity analyst rating the company a underperform, and finally zero equity analysts rating the company a sell with a one year target of $70.92.
Brief Synopsis About AFLAC Incorporated (NYSE:AFL)
Aflac Incorporated is a business holding company. The Company engaged in is supplemental health and life insurance, which is marketed and administered through its subsidiary, American Family Life Assurance Company of Columbus (Aflac). Aflac's insurance business consists of two segments: Aflac Japan and Aflac U.S. Aflac offers insurance policies in Japan and the United States that provide a layer of financial protection against income and asset loss. Aflac Japan sells voluntary supplemental insurance products, including cancer plans, general medical indemnity plans, medical/sickness riders, care plans, living benefit life plans, ordinary life insurance plans and annuities. Aflac U.S. sells supplemental insurance products, including products designed to protect individuals from depletion of assets, such as accident, cancer, critical illness/care, hospital intensive care, hospital indemnity, fixed-benefit dental, and vision care plans and loss-of-income products.
Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with MarketBeat.com's FREE daily email newsletter.